BLACKBERRY is a Percutaneous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Allergy Laboratories, Inc.. The primary component is Blackberry.
Product ID | 54575-353_dbe7bebd-e445-4e59-8302-e706b795fbde |
NDC | 54575-353 |
Product Type | Human Prescription Drug |
Proprietary Name | BLACKBERRY |
Generic Name | Blackberry |
Dosage Form | Injection, Solution |
Route of Administration | PERCUTANEOUS; SUBCUTANEOUS |
Marketing Start Date | 1972-08-29 |
Marketing Category | BLA / BLA |
Application Number | BLA102192 |
Labeler Name | Allergy Laboratories, Inc. |
Substance Name | BLACKBERRY |
Active Ingredient Strength | 1 g/20mL |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 1972-08-29 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA102192 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1972-08-29 |
Inactivation Date | 2020-01-31 |
Marketing Category | BLA |
Application Number | BLA102192 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1972-08-29 |
Inactivation Date | 2020-01-31 |
Marketing Category | BLA |
Application Number | BLA102192 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1972-08-29 |
Inactivation Date | 2020-01-31 |
Marketing Category | BLA |
Application Number | BLA102192 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1972-08-29 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
BLACKBERRY | 1 g/20mL |
NDC | Brand Name | Generic Name |
---|---|---|
36987-1298 | Blackberry | Blackberry |
36987-1299 | Blackberry | Blackberry |
36987-1300 | Blackberry | Blackberry |
36987-1301 | Blackberry | Blackberry |
49288-0054 | Blackberry | Blackberry |
54575-353 | BLACKBERRY | blackberry |